To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure firstname.lastname@example.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
To compare the effectiveness of recombinant follicle stimulating hormone (rFSH) with human menopausal gonadotropin (hMG), one should make this comparison for ovulation induction then for controlled ovarian hyperstimulation in in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) cycles. This chapter compares rFSH with hMG in cryothawed cycles. A cost-effectiveness study of hMG compared to rFSH in a developing country setting was conducted which demonstrated that hMG is more cost-effective than rFSH. The cost saving using highly purified (HP)-hMG remained after varying model parameters in a probabilistic sensitivity analysis. Recently a long acting rFSH, corifollitropin alfa, has been proposed to be a suitable substitution for daily rFSH administration in women undergoing controlled ovarian stimulation in IVF/ICSI cycles. hMG and rFSH have been used to improve sperm parameters in idiopathic male infertility with the goal of increasing pregnancy rates.